[Outpatient cardiac phase III rehabilitation at a Viennese institution - retrospective cohort study]

Brigitte Piso1, Heinz Tüchler, Michael Gyimesi

  • 1Ludwig Boltzmann Institut für Health Technology Assessment, Wien, Austria. brigitte.piso@hta.lbg.ac.at

Insights

Cardiac Phase III (Ph-III) rehabilitation may reduce mortality risk but increase re-events like stent implantations. Further research is needed to confirm effectiveness due to study design limitations.

Area of Science:

  • Cardiology
  • Public Health
  • Rehabilitation Medicine

Background:

  • Retrospective cohort study evaluating the cardiac Phase III (Ph-III) rehabilitation program.
  • Analysis of effectiveness and sustainability of outpatient cardiac rehabilitation provided by the Centre for Outpatient Rehabilitation (ZAR).

Purpose of the Study:

  • To assess the impact of Ph-III cardiac rehabilitation on patient outcomes.
  • To determine the effectiveness and sustainability of the ZAR's Ph-III program.

Main Methods:

  • Analysis of routine data from 451 patients in the intervention group (IG) receiving Ph-III and 781 patients in the control group (KG) not receiving Ph-III.
  • Median observation period of 2.73 years.

Main Results:

  • A trend towards 30% less mortality in the IG compared to the KG (relative risk [rr] = 0.70; p = 0.108).
  • Increased re-events, primarily stent implantations, observed in the IG (rr = 1.34; p = 0.095).
  • Significant differences in baseline characteristics between the IG and KG.

Conclusions:

  • Lower mortality risk in the IG may be attributed to close care, healthier behavior, or selection bias in the KG.
  • Causality of potential positive effects cannot be confirmed due to the study's retrospective design.
  • Further investigation is required to validate the program's effectiveness.
Abstract

Related Concept Videos

Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...